← Back to Search

Chemotherapy

Diet Variation for Environmental Exposures

Phase < 1
Waitlist Available
Research Sponsored by Oregon State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up -7 days and 48 hours
Awards & highlights

Study Summary

This trial looked at the levels of a cancer-causing compound, benzo[a]pyrene, in the blood and urine of people who had just been exposed to it, after eating Brussels sprouts, and after taking a supplement containing DIM.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~-7 days and 48 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and -7 days and 48 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Plasma and urine 14C-BaP and 14C-BaP metabolite levels after oral dose
Secondary outcome measures
Area under plasma concentration of 14C-BaP versus time curve AUC
Metabolites of 14C-BaP in plasma
Metabolites of 14C-BaP in urine
+7 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: DIM supplement before 50 ng doseExperimental Treatment1 Intervention
Subjects will consume 300 mg DIM supplement ( 2 capsules of BioResponse DIM® 150) each evening for 7 days prior to taking capsule containing 50 ng (5.4 nCi) [14C]-benzo[a]pyrene (BaP). A 300 mg DIM dose will be co-administrated with the 50 ng BaP dose
Group II: Brussels sprouts before 50 ng doseExperimental Treatment1 Intervention
Subjects will consume 50 g (about 1/2 cup) of lightly steamed Brussels sprouts each evening for 7 days prior to taking capsule containing 50 ng (5.4 nCi) [14C]-benzo[a]pyrene (BaP)
Group III: 50 ng doseExperimental Treatment1 Intervention
Capsule containing 50 ng (5.4 nCi) [14C]-benzo[a]pyrene (BaP)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Brussels sprouts before 50 ng dose
2019
Completed Early Phase 1
~10
DIM supplement before 50 ng dose
2019
Completed Early Phase 1
~10
[14C]-benzo[a]pyrene
2018
Completed Early Phase 1
~20

Find a Location

Who is running the clinical trial?

Oregon State UniversityLead Sponsor
49 Previous Clinical Trials
8,374 Total Patients Enrolled
3 Trials studying Environmental Exposures
453 Patients Enrolled for Environmental Exposures
National Institute of Environmental Health Sciences (NIEHS)NIH
284 Previous Clinical Trials
1,232,730 Total Patients Enrolled
12 Trials studying Environmental Exposures
4,759 Patients Enrolled for Environmental Exposures
Lawrence Livermore National LaboratoryOTHER
5 Previous Clinical Trials
86 Total Patients Enrolled
2 Trials studying Environmental Exposures
13 Patients Enrolled for Environmental Exposures

Media Library

[14C]-benzo[a]pyrene (Chemotherapy) Clinical Trial Eligibility Overview. Trial Name: NCT03802721 — Phase < 1
Environmental Exposures Research Study Groups: Brussels sprouts before 50 ng dose, DIM supplement before 50 ng dose, 50 ng dose
Environmental Exposures Clinical Trial 2023: [14C]-benzo[a]pyrene Highlights & Side Effects. Trial Name: NCT03802721 — Phase < 1
[14C]-benzo[a]pyrene (Chemotherapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03802721 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this investigation include elderly participants under 80 years of age?

"This medical study is open to adults aged 21 and over, up until the age of 65."

Answered by AI

Am I able to enroll in this clinical investigation?

"This investigation is searching for 7 individuals aged 21-65 who have experienced environmental exposures. To qualify, participants must abstain from consuming cruciferous vegetables, I3C or DIM supplements, smoked and cured meats or cheeses, as well as charcoal grilled food during the study period (gas grilling being an exception). Applicants should be in a generally good health condition with no major changes to their physical state since prior studies 8233 and 8554 if applicable. Female volunteers must either be postmenopausal or surgically sterilized so that there will not be any possible fetal exposure risks. Furthermore, they are encouraged to forego blood"

Answered by AI

Are members of the public being sought for this experimental research?

"Regrettably, the information posted on clinicaltrials.gov suggest that this research is no longer enrolling participants; it was initially published on January 24th 2019 and last updated almost three years ago. Nevertheless, 15 other trials are currently recruiting candidates to join their studies."

Answered by AI
~1 spots leftby Apr 2025